Iron sucrose

Clinical data
Trade names	Venofer
AHFS/Drugs.com	FDA Professional Drug Information
Pregnancy category	US: B (No risk in non-human studies)
Legal status	US: ℞-only
Routes of administration	Intravenous
Identifiers
ATC code	B03AC
Chemical data
Formula	[Na2Fe5O8(OH) •3(H2O)]n •m(C12H22O11)
Molar mass	34,000 to 60,000 daltons

Iron sucrose (brand name Venofer) is an intravenously administered iron product indicated in the treatment of iron deficiency anemia.^[1] It is frequently used in patients undergoing hemodialysis, those undergoing erythropoietin therapy, and/or patients who have chronic kidney disease. It is a type 2 complex which limits the maximum dose that can be given to 200mg which requires several administrations.

References

↑ "Iron Sucrose (Intravenous Route)". Mayo Clinic. Retrieved 22 January 2016.

External links

Venofer entry on Drugs.com
Venofer brand website

Other hematological agents

Antianemic
preparations
(B03)

Erythropoietins	Darbepoetin alfa Methoxy polyethylene glycol-epoetin beta Peginesatide

Iron supplements	Ferrous ascorbate Ferrous aspartate Ferrous carbonate Ferrous chloride Ferrous fumarate Ferrous gluconate Ferrous glycine sulfate Ferrous iodine Ferrous succinate Ferrous sulfate Ferrous tartrate Iron sucrose Sodium ferric gluconate complex

Blood substitutes and
perfusion solutions (B05)

Dextran
Gelatin agents
Hemoglobin crosfumaril
Hemoglobin raffimer
Hydroxyethyl starch
Icodextrin
Mannitol
Serum albumin
Sorbitol

Enzymes (B06AA)

Drugs used i hereditary
angioedema (B06AC)

This article is issued from Wikipedia - version of the Saturday, January 23, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.